PerkinElmer's Q2 Revenues Rise 4 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – PerkinElmer reported after the close of the market Thursday that its second-quarter revenues increased 4 percent year over year, beating Wall Street estimates on the top and bottom line.

The Waltham, Mass.-based firm brought in total revenues of $543.3 million for the three months ended June 30, compared to $521.8 million for the second quarter of 2012. Analysts, on average, had expected revenues of $533 million.

Its organic revenue growth for the quarter was 3 percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

It's too difficult to correct or retract a flawed scientific paper, researchers write in Nature.

A proposed bill would require NSF to only fund research that's in "the national interest."

Australia's Commonwealth Scientific and Industrial Research Organisation plans to eliminate up to 350 jobs.

In PLOS this week: researchers explore the transfer of host genetic material into viruses, and more.